Kim L L Habets

Summary

Affiliation: Leiden University
Country: The Netherlands

Publications

  1. ncbi Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice
    Kim L L Habets
    Division of Biopharmaceutics, Leiden Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden University, PO Box 9502, 2300 RA Leiden, The Netherlands
    Cardiovasc Res 85:622-30. 2010
  2. ncbi Effects of deletion of macrophage ABCA7 on lipid metabolism and the development of atherosclerosis in the presence and absence of ABCA1
    Illiana Meurs
    Division of Biopharmaceutics, Leiden Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden University, Leiden, The Netherlands
    PLoS ONE 7:e30984. 2012
  3. ncbi Vaccination against TIE2 reduces atherosclerosis
    Arnaud D Hauer
    Division of Biopharmaceutics, Leiden University, 2333 CC, Leiden, The Netherlands
    Atherosclerosis 204:365-71. 2009
  4. ncbi Macrophage ABCA5 deficiency influences cellular cholesterol efflux and increases susceptibility to atherosclerosis in female LDLr knockout mice
    Dan Ye
    Division of Biopharmaceutics, LACDR, Leiden University, The Netherlands
    Biochem Biophys Res Commun 395:387-94. 2010
  5. ncbi Receptor-mediated targeting of cathepsins in professional antigen presenting cells
    Ulrik Hillaert
    Leiden Institute of Chemistry, Leiden University, P O Box 9052, 2300 RA Leiden, The Netherlands
    Angew Chem Int Ed Engl 48:1629-32. 2009

Collaborators

  • Johan Kuiper
  • Dan Ye
  • Ying Zhao
  • Suzanne Korporaal
  • Ruud Out
  • Rene E M Toes
  • Illiana Meurs
  • Theo J C Van Berkel
  • Arnaud D Hauer
  • Ulrik Hillaert
  • Miranda Van Eck
  • Giovanna Chimini
  • Emmanuelle Josselin
  • Reeni B Hildebrand
  • Laura Calpe-Berdiel
  • A Mieke Mommaas
  • Martijn Verdoes
  • Joerg Krueger
  • Ferry Ossendorp
  • Athanasios Saragliadis
  • Bogdan I Florea
  • Gijsbert A van der Marel
  • Ralph A Reisfeld
  • Paula de Vos
  • Hermen S Overkleeft
  • Eva J A van Wanrooij
  • Anastasios Saragliadis
  • Christoph Driessen
  • Serge Van Calenbergh

Detail Information

Publications5

  1. ncbi Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice
    Kim L L Habets
    Division of Biopharmaceutics, Leiden Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden University, PO Box 9502, 2300 RA Leiden, The Netherlands
    Cardiovasc Res 85:622-30. 2010
    ..In this study, we transferred oxLDL-pulsed mature DCs (mDCs) to LDL receptor-null (LDLr(-/-)) mice and examined the effects on atherosclerosis...
  2. ncbi Effects of deletion of macrophage ABCA7 on lipid metabolism and the development of atherosclerosis in the presence and absence of ABCA1
    Illiana Meurs
    Division of Biopharmaceutics, Leiden Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden University, Leiden, The Netherlands
    PLoS ONE 7:e30984. 2012
    ..Our data indicate that ABCA7 may play a role in T cell proliferation and erythropoeisis in spleen...
  3. ncbi Vaccination against TIE2 reduces atherosclerosis
    Arnaud D Hauer
    Division of Biopharmaceutics, Leiden University, 2333 CC, Leiden, The Netherlands
    Atherosclerosis 204:365-71. 2009
    ..TIE2(+) cells play a crucial role in processes that are involved in atherosclerosis, such as angiogenesis. Therefore, the specific deletion of TIE2(+) cells by means of DNA vaccination may affect atherosclerosis...
  4. ncbi Macrophage ABCA5 deficiency influences cellular cholesterol efflux and increases susceptibility to atherosclerosis in female LDLr knockout mice
    Dan Ye
    Division of Biopharmaceutics, LACDR, Leiden University, The Netherlands
    Biochem Biophys Res Commun 395:387-94. 2010
    ..To determine the role of macrophage ATP-binding cassette transporter A5 (ABCA5) in cellular cholesterol homeostasis and atherosclerotic lesion development...
  5. ncbi Receptor-mediated targeting of cathepsins in professional antigen presenting cells
    Ulrik Hillaert
    Leiden Institute of Chemistry, Leiden University, P O Box 9052, 2300 RA Leiden, The Netherlands
    Angew Chem Int Ed Engl 48:1629-32. 2009
    ..Uptake of the probe in professional antigen presenting cells and subsequent labeling of cathepsins proceeded in a mannose-receptor dependent manner...